MedTrace Logo

Effect of Midazolam and Dexmedetomidine on Heart Function - A Randomized MRI-based Study.

NCT04529187 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-08-27

No results posted yet for this study

Summary

To compare the changes in heart function, induced after sedation with midazolam or dexmedetomidine, using cardiac magnetic resonance imaging (MRI).

This study is a randomized unmasked study, in which participant will be allocated by the envelop method into the dexmedetomidine (DEX) group or into the midazolam (MID) group.

Conditions

  • Cardiac Function
  • Sedation
  • Magnetic Resonance Imaging

Interventions

DRUG

Midazolam

To monitor the changes in heart function induced after midazolam sedation using cardiac MRI.

DRUG

Dexmedetomidine

To monitor the changes in heart function induced after dexmedetomidine sedation using cardiac MRI.

Sponsors & Collaborators

  • Masaryk Hospital Krajská zdravotní a.s.

    lead OTHER

Principal Investigators

  • Nedal Omran, M.D · Masaryk Hospital and UJEP, Usti nad Labem, Czech Republic.

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04529187 on ClinicalTrials.gov